These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

521 related items for PubMed ID: 16813940

  • 21. Evaluating use of higher dose oxybutynin in combination with desmopressin for refractory nocturnal enuresis.
    Berkenwald A, Pires J, Ellsworth P.
    J Pediatr Urol; 2016 Aug; 12(4):220.e1-6. PubMed ID: 27373215
    [Abstract] [Full Text] [Related]

  • 22. The use of desmopressin in the management of nocturnal enuresis in patients with spinal cord injury.
    Zahariou A, Karagiannis G, Papaioannou P, Stathi K, Michail X.
    Eura Medicophys; 2007 Sep; 43(3):333-8. PubMed ID: 17021585
    [Abstract] [Full Text] [Related]

  • 23. Failure of monotherapy in primary monosymptomatic enuresis: a combined desmopressin and propiverine treatment regimen improves efficacy outcomes.
    Alloussi SH, Mürtz G, Gitzhofer S, Eichel R, Lang C, Madersbacher H, Strugala G, Alloussi S.
    BJU Int; 2009 Jun; 103(12):1706-12. PubMed ID: 19154456
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Evidence of partial anti-enuretic response related to poor pharmacodynamic effects of desmopressin nasal spray.
    De Guchtenaere A, Raes A, Vande Walle C, Hoebeke P, Van Laecke E, Donckerwolcke R, Vande Walle J.
    J Urol; 2009 Jan; 181(1):302-9; discussion 309. PubMed ID: 19013601
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Long-term desmopressin response in primary nocturnal enuresis: open-label, multinational study.
    Lottmann H, Baydala L, Eggert P, Klein BM, Evans J, Norgaard JP.
    Int J Clin Pract; 2009 Jan; 63(1):35-45. PubMed ID: 19125991
    [Abstract] [Full Text] [Related]

  • 29. Predictive parameters of response to desmopressin in primary nocturnal enuresis.
    Van Herzeele C, Evans J, Eggert P, Lottmann H, Norgaard JP, Vande Walle J.
    J Pediatr Urol; 2015 Aug; 11(4):200.e1-8. PubMed ID: 26059526
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. No relationship between family history of enuresis and response to desmopressin.
    Schaumburg HL, Rittig S, Djurhuus JC.
    J Urol; 2001 Dec; 166(6):2435-7. PubMed ID: 11696806
    [Abstract] [Full Text] [Related]

  • 32. Evidence against a synergistic effect of desmopressin with conditioning in the treatment of nocturnal enuresis.
    Gibb S, Nolan T, South M, Noad L, Bates G, Vidmar S.
    J Pediatr; 2004 Mar; 144(3):351-7. PubMed ID: 15001941
    [Abstract] [Full Text] [Related]

  • 33. Comparison of the Efficacy of Tolterodine versus Oxybutynin in the Treatment of Children with Desmopressin-Resistant Enuresis: A Randomized Controlled Clinical Trial.
    Ezodin N, Sarouei M, Khademlo M, Milani SH, Yousefi S, Mohammadjafari H.
    Ethiop J Health Sci; 2023 Jul; 33(4):611-620. PubMed ID: 38784212
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Evaluation of Urinary Aquaporin 2 and Plasma Copeptin as Biomarkers of Effectiveness of Desmopressin Acetate for the Treatment of Monosymptomatic Nocturnal Enuresis.
    Hara T, Ohtomo Y, Endo A, Niijima S, Yasui M, Shimizu T.
    J Urol; 2017 Oct; 198(4):921-927. PubMed ID: 28457803
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 27.